A Study of HB0030 Injection in Patients With Advanced Solid Tumors
Clinical trial NCT05706207 · UNKNOWN
Trial details
- NCT number
- NCT05706207
- Sponsor
- Huabo Biopharm Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2023-09-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.